Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics

Author:

Martin-Blondel Guillaume1,Ruiz Stéphanie2,Murris Marlène3,Faguer Stanilas4,Duhalde Véronigue5,Eyvrard Frédéric5,Izopet Jacques6,Mansuy Jean-Michel6,Rolland Yves7,Delavigne Karen8,Guimbaud Rosine9,Pugnet Grégory10,Conil Jean-Marie2,Georges Bernard2,Delobel Pierre1,Minville Vincent2,Silva Sifontes Stein11,Concordet Didier12,Gandia Peggy1213

Affiliation:

1. Service des Maladies Infectieuses et Tropicales, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France

2. Service de Réanimation - Rangueil, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France

3. Service de Pneumologie - CRCM, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France

4. Pôle de Néphrologie et Transplantation d’Organes, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France

5. Pôle Pharmacie, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France

6. Laboratoire de Virologie, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France

7. Pôle de Gériatrie, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France

8. Service d’Hématologie, IUCT-Oncopole, Toulouse, France

9. Pôle des Maladies de l’Appareil Digestif, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France

10. Service de Médecine Interne, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France

11. Service de Réanimation - Purpan, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France

12. UMR INTHERES, INRA-ENVT, Toulouse, France

13. Laboratoire de Pharmacocinétique et Toxicologie, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France

Abstract

Abstract Different dosage regimens of hydroxychloroquine are used to manage coronavirus disease 2019 (COVID-19) patients, without information on the pharmacokinetics in this population. Blood samples (n = 101) were collected from 57 COVID-19 patients for 7 days, and concentrations were compared with simulated kinetic profiles. Hydroxychloroquine exposure is low and cannot be predicted by other populations.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Reference13 articles.

1. No evidence of rapid;Molina;Médecine et Maladies Infectieuses,2020

2. Hydroxychloroquine and azithromycin;Gautret;Int J Antimicrob Agents,2020

3. A pilot study;Chen;J Zhejiang University (Medical Science),2020

4. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases;Rainsford;Inflammopharmacology,2015

5. Steady-state pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus;Al-Rawi;Lupus,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3